Taycor Financial announced Suzanne Costa has been hired and appointed to lead the Biotechnology and Medical Device Division. Costa assumed the role of vice president of biotechnology effective May 1 and joins the team with over 13 years of equipment finance experience.

“We are very excited to welcome Suzanne Costa, who is bringing us her broad experience in supporting both life science customers and vendor partners,” said Michael Hong, President of Taycor. “Suzanne has a strong understanding of program development within the biotech industry and helped roll out creative product specific leasing programs at her former employer Applied Biosystems. Our goal is to make these programs available not only to the institutional customers but also the small and medium-sized business community.”

Costa has experience both from a high-level portfolio and program development standpoint as well as on the field working side by side with various technical sales teams.

“After visiting and spending time with members at Taycor headquarters, it’s refreshing to see the in-house development in technology has not come at the cost of personalized customer experience,” Costa said. “The intelligent blending of technology and individual service provides a seamless experience to obtain the equipment infrastructure companies need. I feel confident that Taycor can offer partners of all sizes creative and flexible financing programs.”

Costa will focus primarily on portfolio growth and program development in the biotechnology and medical device asset verticals. Prior to joining Taycor Financial, Costa managed the North American territory’s portfolio development and program initiatives for Applied Biosystems, now Thermo Fisher Scientific Corporation; Senior Portfolio Manager for CIT Group Inc.; Senior Portfolio Representative in the Vendor Finance Division of Fleet Capital Corporation; and Division Administrator for Merrill Lynch Business Credit Corporation. Costa holds a bachelor’s degree in finance from DePaul University in Chicago.